Skip to content

Regatta Lateral System 36-230845-10Recalls & reported problems

Seaspine Orthopedics Corporation · Lateral Implant, 23mm x 8mm x 45mm, 10 Deg · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10889981162108), received between Jul 10, 2020 and Jul 10, 2020 — classified as 1 injury.

The most frequently reported specific device problem is “Migration” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Migration1

Patient problems

  • Patient Problem/Medical Problem1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryJul 10, 2020Migration; Migration

    ON (B)(6) 2020, THE PATIENT UNDERWENT L3-L5 LATERAL LUMBAR INTERBODY FUSION (LLIF) SURGERY CONSISTING OF THE REGATTA LATERAL SYSTEM. ON 11 JUN 2020, SEASPINE WAS MADE AWARE OF A POSTOPERATIVE IMPLANT MIGRATION AT THE L4/5 LEVEL. A REVISION SURGERY OCCURRED ON (B)(6) 2020 TO REPOSITION THE IMPLANT AND SUPPLEMENT WITH POSTERIOR FIXATION.

    Patient problems: Patient Problem/Medical Problem

    MAUDE report 10261317 ↗

Other Intervertebral fusion device with bone graft, lumbar devices

All Intervertebral fusion device with bone graft, lumbar devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page